Business Context and Reporting Period
This Form 8-K was filed by Syndax Pharmaceuticals, Inc. on February 6, 2019. The report details the Board of Directors' approval of compensation arrangements for named executive officers, including 2018 cash bonuses, 2019 base salaries, bonus targets, and annual equity awards.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive compensation.
| Executive | 2018 Cash Bonus | 2019 Base Salary | 2019 Bonus Target | 2019 Option Grant (Shares) |
|---|---|---|---|---|
| Briggs W. Morrison, M.D. (CEO) | $247,660 | $583,055 | 50% | 354,000 |
| Michael A. Metzger (President & COO) | $221,540 | $521,566 | 50% | 240,000 |
| Michael L. Meyers, M.D., Ph.D. (SVP, CMO) | $144,200 | $424,360 | 40% | 104,325 |
Material Changes
The filing reports the implementation of new 2019 annual base salaries effective January 1, 2019, and the granting of new stock options. The filing text does not provide comparative data to quantify changes versus prior periods.
Guidance, Outlook, and Risks
Equity Award Terms:
- Exercise Price: $6.38 per share (closing price on February 6, 2019).
- Term: 10 years from the grant date.
- Vesting: Options vest in two tranches: 50% over 48 monthly installments starting February 6, 2019, and 50% upon the achievement of certain company milestones.
Management Commentary: The Board approved these recommendations based on the Compensation Committee's review. The filing does not contain forward-looking financial guidance or specific risk factors beyond the standard vesting conditions.
Investor Verification Checklist
- Verify the total number of shares authorized under the 2015 Omnibus Incentive Plan to assess dilution impact.
- Review the specific "certain milestones" defined for the performance-based vesting portion of the stock options.
- Confirm the company's cash position to ensure it can fund the approved 2018 cash bonuses totaling approximately $613,400.
- Check subsequent filings for updates on the achievement of the performance milestones tied to the equity awards.